Bumrungrad Hospital Public Co., Ltd.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. carries a market capitalization of 149.45B, placing it among publicly traded companies globally. Its enterprise value stands at 142.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bumrungrad Hospital Public Co., Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. has 794.97M shares outstanding.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. trades at a trailing price-to-earnings ratio of 19.67. The price-to-sales ratio is 5.86, and the price-to-book ratio stands at 5.46.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. trades at an EV/EBITDA multiple of 13.78 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.58 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.47 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Bumrungrad Hospital Public Co., Ltd. trades at an EV/FCF ratio of 33.14, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 142.32B versus a market cap of 149.45B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. maintains a current ratio of 3.36, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.36, indicating conservative leverage, while an interest coverage ratio of 2,009.80 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. posted a return on equity (ROE) of 27.13, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 25.72 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 22.71, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 26.55, useful for judging operating efficiency across full business cycles. The company generates approximately 5.72M in revenue per employee across its workforce of 4,463.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 39.73 indicates how many times Bumrungrad Hospital Public Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. recorded 1.76B in income tax expense. That works out to an effective tax rate of 18.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.41B, leaving 7.60B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Bumrungrad Hospital Public Co., Ltd.'s stock has gained approximately 9.67% over the past 52 weeks. The 50-day moving average sits at 194.54, while the 200-day moving average is 180.35.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. generated 25.53B in revenue and converted that into 7.60B in net income, yielding earnings per share of 8.82. EBITDA reached 10.33B, while operating income came in at 9.21B.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. holds 7.57B in cash and equivalents against 99.64M in total debt, resulting in a net debt position of -3.88B. Total book value stands at 27.38B, with working capital of 10.04B providing operational flexibility.

Bumrungrad Hospital Public Co., Ltd. produced 7.04B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.74B in capital expenditures, free cash flow totaled 4.29B - equivalent to 5.40 per share.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. posted a gross margin of 51.98, reflecting its pricing power and cost economics. The operating margin of 36.08 and net profit margin of 29.77 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. paid dividends of 11.00 per share. The dividend payout ratio of 113.53 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 2.63, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 5.94, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Bumrungrad Hospital Public Co., Ltd. shareholders.

Bumrungrad Hospital Public Co., Ltd.'s most recent stock split took place on May 24, 2004 with a 1:5 split ratio.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. has an Altman Z-Score of 19.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.